143
Views
0
CrossRef citations to date
0
Altmetric
Retina and Choroid

Evaluation of Optical Coherence Tomography Angiography Findings in Pars Planitis and Multiple Sclerosis Associated Intermediate Uveitis in Remission

ORCID Icon, , &
Pages 717-724 | Received 07 Aug 2023, Accepted 20 Feb 2024, Published online: 03 Mar 2024

References

  • Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987; 103(2):234–235. doi: 10.1016/s0002-9394(14)74235-7.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G: standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140(3):509–516.
  • Standardization of uveitis nomenclature working G: classification criteria for pars planitis. Am J Ophthalmol. 2021; 228:268–274.
  • Vitale AZ, Foster CS. Diagnosis and treatment of uveitis. In: Intermediate Uveitis. edn. Edited by Foster CS VA. Philadelphia: w.B.Saunders and Company; 2002: p. 844–857.
  • Shoughy SS, Kozak I, Tabbara KF. Associations of systemic diseases with intermediate uveitis. Ophthalmic Epidemiol. 2016; 23(1):27–31. doi: 10.3109/09286586.2015.1119286.
  • Ness T, Boehringer D, Heinzelmann S. Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis. 2017; 12(1):81. doi: 10.1186/s13023-017-0638-9.
  • Touhami S, Leclercq M, Stanescu-Segall D, Touitou V, Bodaghi B. Differential diagnosis of vitritis in adult patients. Ocul Immunol Inflamm. 2021; 29(4):786–795. doi: 10.1080/09273948.2021.1898001.
  • Vadboncoeur J, Biernacki K, Prat A, Jaworski L. Multiple sclerosis-associated uveitis. Expert Rev Ophthalmol. 2017; 12(1):57–67. doi: 10.1080/17469899.2017.1264875.
  • Abraham A, Nicholson L, Dick A, Rice C, Atan D. Intermediate uveitis associated with MS: diagnosis, clinical features, pathogenic mechanisms, and recommendations for management. Neurol Neuroimmunol Neuroinflamm. 2021; 8(1):e909. doi: 10.1212/NXI.0000000000000909.
  • Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol. 2021; 99(6):592–603. doi: 10.1111/aos.14697.
  • Przezdziecka-Dolyk J, Wegrzyn A, Turno-Krecicka A, Misiuk-Hojlo M. Immunopathogenic background of pars planitis. Arch Immunol Ther Exp (Warsz). 2016; 64(2):127–137.
  • Petrushkin H, Kidd D, Pavesio C. Intermediate uveitis and multiple sclerosis: to scan or not to scan. Br J Ophthalmol. 2015; 99(12):1591–1593. doi: 10.1136/bjophthalmol-2015-307269.
  • Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B. Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group. Int Ophthalmol. 2023; 43(10):3681–3693. doi: 10.1007/s10792-023-02778-z.
  • Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001; 57(10):1885–1888. doi: 10.1212/wnl.57.10.1885.
  • Ozdemir HB, Ozdal PC. Clinical characteristics and treatment of pars planitis: an adalimumab experience. Graefes Arch Clin Exp Ophthalmol. 2022; 260(2):561–569. doi: 10.1007/s00417-021-05398-4.
  • Schwartz DM, Fingler J, Kim DY, Zawadzki RJ, Morse LS, Park SS, Fraser SE, Werner JS. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology. 2014; 121(1):180–187. doi: 10.1016/j.ophtha.2013.09.002.
  • de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous. 2015; Apr 151(5):5.
  • Hassan M, Agarwal A, Afridi R, daSilva MJ, Karaca I, Sadiq MA, Nguyen QD, Do DV. The role of optical coherence tomography angiography in the management of uveitis. Int Ophthalmol Clin. 2016; 56(4):1–24. doi: 10.1097/IIO.0000000000000130.
  • Hagag AM, Gao SS, Jia Y, Huang D. Optical coherence tomography angiography: technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol. 2017; 7(3):115–129. doi: 10.4103/tjo.tjo_31_17.
  • Dingerkus VLS, Munk MR, Brinkmann MP, Freiberg FJ, Heussen FMA, Kinzl S, Lortz S, Orgul S, Becker M. Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis. J Ophthalmic Inflamm Infect. 2019; 9(1):10.
  • Celik Buyuktepe T, Özmert E, Demirel S, Batıoğlu F. Role of inflammation in retinal microcirculation in diabetic eyes: correlation between aqueous flare and microvascular findings. Ophthalmologica. 2020; 243(5):391–398. doi: 10.1159/000507089.
  • Ebrahimiadib N, Maleki A, Fadakar K, Manhapra A, Ghassemi F, Foster CS. Vascular abnormalities in uveitis. Surv Ophthalmol. 2021; 66(4):653–667. doi: 10.1016/j.survophthal.2020.12.006.
  • Herbort CP, Jr, Takeuchi M, Papasavvas I, Tugal-Tutkun I, Hedayatfar A, Usui Y, Ozdal PC, Urzua CA. Optical coherence tomography angiography (OCT-A) in uveitis: a literature review and a reassessment of its real role. Diagnostics. 2023;13(4):601. doi: 10.3390/diagnostics13040601.
  • Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET, Jr., Neri P, Albini TA, Gupta V, Baynes K, Srivastava SK. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res. 2017;59:178–201. doi: 10.1016/j.preteyeres.2017.04.005.
  • Kim AY, Rodger DC, Shahidzadeh A, Chu Z, Koulisis N, Burkemper B, Jiang X, Pepple KL, Wang RK, Puliafito CA, et al. Quantifying retinal microvascular changes in uveitis using spectral-domain optical coherence tomography angiography. Am J Ophthalmol. 2016; 171:101–112. doi: 10.1016/j.ajo.2016.08.035.
  • Yalcinkaya G, Altan C, Basarir B, Cakir I. Retinal optical coherence tomography angiography findings of acute anterior uveitis. Int Ophthalmol. 2022; 42(5):1409–1418. doi: 10.1007/s10792-021-02129-w.
  • Aksoy FE, Altan C, Basarir B, Garip D, Pasaoglu I, Perente I, Yigit U, Taskapili M. Analysis of retinal microvasculature in Fuchs’ uveitis syndrome. Retinal microvasculature in Fuchs’ uveitis. J Fr Ophtalmol. 2020; 43(4):324–329. doi: 10.1016/j.jfo.2019.10.004.
  • Wintergerst MWM, Pfau M, Müller PL, Berger M, de Sisternes L, Holz FG, Finger RP. Optical coherence tomography angiography in intermediate uveitis. Am J Ophthalmol. 2018; 194:35–45. doi: 10.1016/j.ajo.2018.06.023.
  • Tian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR. Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2019; 103(9):1289–1295. doi: 10.1136/bjophthalmol-2018-313078.
  • Tian M, Tappeiner C, Zinkernagel MS, Wolf S, Munk MR. Swept-source optical coherence tomography angiography reveals vascular changes in intermediate uveitis. Acta Ophthalmol. 2019; 97(5):e785–e791.
  • Sezenöz AS, Güngör SG, Kurt RA, Gökgöz G, Adwan N, Toprak U. Macular vessel densities by optical coherence tomography angiography in patients with intermediate uveitis. Indian J Ophthalmol. 2023; 71(1):153–160. doi: 10.4103/ijo.IJO_1298_22.
  • Wang X, Jia Y, Spain R, Potsaid B, Liu JJ, Baumann B, Hornegger J, Fujimoto JG, Wu Q, Huang D. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol. 2014; 98(10):1368–1373. doi: 10.1136/bjophthalmol-2013-304547.
  • Farci R, Carta A, Cocco E, Frau J, Fossarello M, Diaz G. Optical coherence tomography angiography in multiple sclerosis: a cross-sectional study. PLoS One. 2020; 15(7):e0236090. doi: 10.1371/journal.pone.0236090.
  • Cordon B, Vilades E, Orduna E, Satue M, Perez-Velilla J, Sebastian B, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E. Angiography with optical coherence tomography as a biomarker in multiple sclerosis. PLoS One. 2020; 15(12):e0243236. doi: 10.1371/journal.pone.0243236.
  • Standardization of uveitis nomenclature working G: classification criteria for multiple sclerosis-associated intermediate uveitis. Am J Ophthalmol. 2021; 228:72–79.
  • Stamenkovic M, Obradovic D. Retinal periphlebitis in patients with multiple sclerosis. VSP. 2011; 68(7):544–549. doi: 10.2298/VSP1107544S.
  • Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O. Predictors of long-term visual outcome in intermediate uveitis. Ophthalmology. 2017; 124(3):393–398. doi: 10.1016/j.ophtha.2016.11.013.
  • Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007; 144(6):812–817. doi: 10.1016/j.ajo.2007.08.023.
  • Soberon V, Grezemkowsky DM, Concha del Rio LE, Villanueva GS, Morales Canton V, Mercado HQ. Descriptive case series on optical coherence tomography angiography findings of patients with idiopathic intermediate uveitis in a referral ophthalmological centre at Mexico City. J Clin Exp Ophthalmol. 2017; 08(04):2. doi: 10.4172/2155-9570.1000674.
  • Khairallah M, Abroug N, Khochtali S, Mahmoud A, Jelliti B, Coscas G, Lupidi M, Kahloun R, Ben Yahia S. Optical coherence tomography angiography in patients with Behcet uveitis. Retina. 2017; 37(9):1678–1691. doi: 10.1097/IAE.0000000000001418.
  • Aksoy FE, Basarir B, Altan C, Pasaoglu I, İnal A, Tunç U, Ocak OB, Karabulut GO. Retinal microvasculature in the remission period of Behcet’s uveitis. Photodiagnosis Photodyn Ther. 2020; 29:101646. doi: 10.1016/j.pdpdt.2019.101646.
  • Cerquaglia A, Iaccheri B, Fiore T, Fruttini D, Belli FB, Khairallah M, Lupidi M, Cagini C. New insights on ocular sarcoidosis: an optical coherence tomography angiography study. Ocul Immunol Inflamm. 2019; 27(7):1057–1066. doi: 10.1080/09273948.2018.1497665.
  • Hormel TT, Jia Y, Jian Y, Hwang TS, Bailey ST, Pennesi ME, Wilson DJ, Morrison JC, Huang D. Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography. Prog Retin Eye Res. 2021; 80:100878. doi: 10.1016/j.preteyeres.2020.100878.
  • Haacke EM, Ge Y, Sethi SK, Buch S, Zamboni P. An overview of venous abnormalities related to the development of lesions in multiple sclerosis. Front Neurol. 2021; 12:561458. doi: 10.3389/fneur.2021.561458.
  • Stiemer R, Duijvestijn A, Wiggert B, Whitcup S, Zierhut M. High endothelial venules. Kinetics of the expression in IRBP-induced experimental autoimmune uveitis. Ophthalmologe. 1999; 96(1):40–44. doi: 10.1007/s003470050374.
  • Lee SJ, Benveniste EN. Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol. 1999; 98(2):77–88. doi: 10.1016/s0165-5728(99)00084-3.
  • Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J Clin Invest. 2001; 107(8):995–1006. doi: 10.1172/JCI11717.
  • Dewispelaere R, Lipski D, Foucart V, Bruyns C, Frère A, Caspers L, Willermain F. ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis. Exp Eye Res. 2015; 137:94–102. doi: 10.1016/j.exer.2015.06.017.
  • Makhoul M, Dewispelaere R, Relvas LJ, Elmaleh V, Caspers L, Bruyns C, Willermain F. Characterization of retinal expression of vascular cell adhesion molecule (VCAM-1) during experimental autoimmune uveitis. Exp Eye Res. 2012; 101:27–35. doi: 10.1016/j.exer.2012.05.012.
  • Chen Y-H, Lightman S, Eskandarpour M, Calder VL. Adhesion molecule targeted therapy for non-infectious uveitis. Int J Mol Sci. 2022; 23(1):503. doi: 10.3390/ijms23010503.
  • Tranos P, Karasavvidou E-M, Gkorou O, Pavesio C. Optical coherence tomography angiography in uveitis. J Ophthalmic Inflamm Infect. 2019; 9(1):21. doi: 10.1186/s12348-019-0190-y.
  • Chalkias IN, Bakirtzis C, Pirounides D, Boziki MK, Grigoriadis N. Optical coherence tomography and optical coherence tomography with angiography in multiple sclerosis. Healthcare (Basel). 2022; 10(8):1386. doi: 10.3390/healthcare10081386.
  • Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F, Cianflone A, Moccia M, Brescia Morra V. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Mult Scler. 2018; 24(13):1706–1714. doi: 10.1177/1352458517729463.
  • Murphy OC, Kwakyi O, Iftikhar M, Zafar S, Lambe J, Pellegrini N, Sotirchos ES, Gonzalez-Caldito N, Ogbuokiri E, Filippatou A, et al. Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures. Mult Scler. 2020; 26(7):815–828. doi: 10.1177/1352458519845116.
  • Yilmaz H, Ersoy A, Icel E. Assessments of vessel density and foveal avascular zone metrics in multiple sclerosis: an optical coherence tomography angiography study. Eye (Lond)). 2020; 34(4):771–778. doi: 10.1038/s41433-019-0746-y.
  • Munk MR, Giannakaki-Zimmermann H, Berger L, Huf W, Ebneter A, Wolf S, Zinkernagel MS. OCT-angiography: a qualitative and quantitative comparison of 4 OCT-A devices. PLoS One. 2017; 12(5):e0177059. doi: 10.1371/journal.pone.0177059.
  • Invernizzi A, Carreño E, Pichi F, Munk MR, Agarwal A, Zierhut M, Pavesio C. Experts opinion: OCTA vs. FFA/ICG in uveitis – which will survive? Ocul Immunol Inflamm. 2023; 31(8):1561–1568. doi: 10.1080/09273948.2022.2084421.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.